FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Top Story

Vaccine cure for RA heads to human trial

A team of scientists at Newcastle University is preparing a small human trial to test a one-shot approach to curing rheumatoid arthritis with a vaccine devised from a patient's white blood cells. The cells are taken from the volunteers and manipulated with a recipe of chemicals, steroids and Vitamin D so they can suppress the immune system rather than spur it. And a single jab could be enough to suppress the auto-immune response that triggers rheumatoid arthritis. Report

Syndicate content

Latest News

Pfizer teams with Cytos to develop new vaccines

Further bolstering its ambitious vaccine program, Pfizer has teamed up with Cytos Biotechnology to develop, manufacture and commercialize vaccines for a defined number of human diseases. Cytos gains Read more...
Tags: vaccine   Cytos   Pfizer  

1918 flu survivors' blood may hold key to better vax

Scientists were able to identify the antibodies that still circulate in the blood of survivors of the deadly 1918 flu outbreak and found that they still proved to be a potent antidote to the disease. Read more...

Critics accuse Merck of hyping cervical cancer risk

Just how important Gardasil has become to Merck's top line is underscored by a New York Times article analyzing the impact of what the pharma company calls "educational programs" and just about Read more...

Study examines cost-effectiveness of Gardasil

A new study in the New England Journal of Medicine questions the cost-effectiveness of Gardasil in older women, saying that the payback is reduced by their increased exposure to the virus that causes Read more...

Nanotech hep B vaccine could revolutionize therapy

Scientists at the University of Michigan are moving closer to human trials of a new nanoemulsion hepatitis B vaccine that could revolutionize therapy in the third world. The nanoemulsion approach Read more...

Other pandemic threats are lurking in H9 virus

H5N1 isn't the only avian virus that threatens to trigger a pandemic. A group of virologists was able to make an H9 virus much more transmissible by changing a single chemical component in the Read more...
Tags: vaccine   H9   Daniel Perez   bird flu  

Woman's immune system may be key to HIV vax

An investigative team at Johns Hopkins has been studying a woman whose natural immunity has quelled the virus she was infected with 10 years ago. Researchers say that she is an 'elite suppressor:' Read more...
Tags: vaccine   HIV/AIDS   cytokines  

Researchers post positive late-stage Heplisav data

Researchers for Dynavax and Merck say that a late-stage trial of their hepatitis B vaccine Heplisav hit the endpoint they were aiming at: non-inferior antibody response compared to GlaxoSmithKline's Read more...